Skip to content
10-K/A

Annual Report

FRAZIER LIFESCIENCES ACQUISITION CORPORATION

0001193125-22-023432

← back to feed
Filed
Jan 31, 2022 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow FY 2020 · Dec 31, 2020 −$500K
Cash And Equivalents FY 2020 · Dec 31, 2020 $1.37M
Cash And Equivalents FY 2020 · Oct 6, 2020 $0
Stockholders Equity FY 2020 · Dec 31, 2020 −$10.54M
Stockholders Equity FY 2020 · Oct 6, 2020 $0
Current Liabilities FY 2020 · Dec 31, 2020 $236.52K
Total Liabilities FY 2020 · Dec 31, 2020 $12.41M
Current Assets FY 2020 · Dec 31, 2020 $1.87M
Total Assets FY 2020 · Dec 31, 2020 $139.87M
Sga Expense FY 2020 · Dec 31, 2020 $120.88K
Net Income FY 2020 · Dec 31, 2020 $41.45K
Operating Income FY 2020 · Dec 31, 2020 −$127.66K